Open Access<p>Lobaplatin-Based Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastasis from Appendiceal and Colorectal Cancer: Safety and Efficacy Profiles</p>
Author(s) -
Wei Pei,
Sicheng Zhou,
Jing Zhang,
Haitao Zhou,
Haipeng Chen,
Jianjun Bi,
Zhaoxu Zheng,
Zheng Liu,
Zheng Jiang,
Wei Zheng,
Qian Liu,
Xishan Wang,
Jianwei Liang,
Qiang Feng
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
ISSN - 1179-1322
DOI - 10.2147/cmar.s281434
Subject(s) - medicine , hyperthermic intraperitoneal chemotherapy , perioperative , colorectal cancer , metastasis , gastroenterology , pathological , chemotherapy , cancer , oncology , cytoreductive surgery , surgery , ovarian cancer
This study aimed to evaluate the safety and efficacy of lobaplatin in hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastasis (PM) arising from colorectal or appendiceal cancer.